We are live on ! Find out more
FIS

FCPM III Services Portfolio holdings

AUM $722M
1-Year Est. Return 73.61%
This Fund
S&P 500
This Quarter Est. Return
+52.52%
1 Year Est. Return
+73.61%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$500M
AUM Growth
+$131M
Cap. Flow
-$18.4M
Cap. Flow %
-3.68%
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
1
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
VOR icon
Vor Biopharma
VOR
+$15.3M
2
REPL icon
Replimune Group
REPL
+$1.59M

Top Sells

Rank Stock Value
1
NAMS icon
NewAmsterdam Pharma
NAMS
+$34M
2
RAPT
RAPT Therapeutics
RAPT
+$1.26M

Sector Composition

Rank Sector Weight
1 Healthcare 99.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NAMS icon
1
NewAmsterdam Pharma
NAMS
$3.47B
$262M 52.36%
9,212,384
-1,419,729
-13% -$34M
DYN icon
2
Dyne Therapeutics
DYN
$3.88B
$69.1M 13.81%
5,462,846
– –
ENGN icon
3
enGene Therapeutics
ENGN
$125M
$65.8M 13.15%
9,632,561
– –
ATXS
4
DELISTED
Astria Therapeutics
ATXS
$29.9M 5.98%
4,107,537
– –
BCYC
5
Bicycle Therapeutics
BCYC
$290M
$26.7M 5.34%
3,452,330
– –
VOR icon
6
Vor Biopharma
VOR
$946M
$18.5M 3.7%
+379,640
New +$15.3M
REPL icon
7
Replimune Group
REPL
$882M
$17.4M 3.48%
4,158,368
+248,672
+6% +$1.59M
RAPT
8
DELISTED
RAPT Therapeutics
RAPT
$8.88M 1.77%
344,237
-95,939
-22% -$1.26M
ENGNW icon
9
enGene Therapeutics Warrants
ENGNW
$3.53M
$2.07M 0.41%
2,878,148
– –

Similar funds

ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
ZAM
Zevin Asset Management Boston, Massachusetts $723M AUM 15.62% 1-Year Est. Return
AF
Apollon Financial Mount Pleasant, South Carolina $723M AUM 24.23% 1-Year Est. Return
UW
Unique Wealth Clearwater, Florida $723M AUM 16.35% 1-Year Est. Return
PPW
Pasadena Private Wealth Pasadena, California $723M AUM 18.72% 1-Year Est. Return
VCM
Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return
FFM
FengHe Fund Management Singapore $724M AUM 196.18% 1-Year Est. Return
WLIM
White Lighthouse Investment Management Bedford, Massachusetts $721M AUM 16.12% 1-Year Est. Return

FCPM III Services's Q3 2025 Portfolio in Review

As of Q3 2025, FCPM III Services held 9 positions worth $500M, up 36% from $369M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

FCPM III Services withdrew a net $18.4M in Q3 2025, reducing 2 holdings. Its largest reduction was NewAmsterdam Pharma, cutting an estimated $34M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 99% a quarter earlier.

Against the trend, FCPM III Services opened a new position in Vor Biopharma worth $18.5M.

  • FCPM III Services's largest Q3 2025 buy was Vor Biopharma: 379,640 shares worth $18.5M.
  • FCPM III Services added most to Replimune Group in Q3 2025, an estimated $1.59M increase.
  • FCPM III Services's biggest Q3 2025 reduction was NewAmsterdam Pharma, cutting an estimated $34M.
  • FCPM III Services's ten largest holdings make up 100% of its $500M portfolio in Q3 2025.
  • FCPM III Services opened 1 new position and closed 0 in Q3 2025.
  • FCPM III Services's portfolio value rose 36% quarter-over-quarter to $500M.

Based on FCPM III Services's 13F filing for Q3 2025, filed 14 Nov 2025.